Moleculin Biotech Inc (MBRX) — Net Asset Quality Index
Moleculin Biotech Inc (MBRX) has a Net Asset Quality Index of 67.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $22.13 Million minus total liabilities of $7.12 Million yields net assets of $15.01 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check MBRX cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Moleculin Biotech Inc Net Asset Quality Index Over Time (2015–2025)
This chart shows how Moleculin Biotech Inc's Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of December 2025, the index stands at 67.8%, representing net assets of $15.01 Million against total assets of $22.13 Million USD. See MBRX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Moleculin Biotech Inc (2015–2025)
The table below presents the year-by-year Net Asset Quality Index for Moleculin Biotech Inc from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Moleculin Biotech Inc (MBRX) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 67.8% | $15.01 Million | $22.13 Million | $7.12 Million | ▲ +32.5 pp |
| 2024 | 35.3% | $5.98 Million | $16.93 Million | $10.95 Million | ▼ -32.9 pp |
| 2023 | 68.2% | $26.07 Million | $38.22 Million | $12.14 Million | ▼ -22.7 pp |
| 2022 | 90.9% | $52.19 Million | $57.42 Million | $5.23 Million | ▼ -3.0 pp |
| 2021 | 93.9% | $78.99 Million | $84.09 Million | $5.10 Million | ▲ +32.6 pp |
| 2020 | 61.3% | $17.89 Million | $29.16 Million | $11.27 Million | ▼ -0.4 pp |
| 2019 | 61.7% | $15.57 Million | $25.23 Million | $9.66 Million | ▼ -11.2 pp |
| 2018 | 72.9% | $14.27 Million | $19.59 Million | $5.31 Million | ▼ -15.0 pp |
| 2017 | 87.9% | $17.12 Million | $19.48 Million | $2.37 Million | ▼ -3.4 pp |
| 2016 | 91.3% | $14.96 Million | $16.39 Million | $1.43 Million | ▲ +2742.3 pp |
| 2015 | -2651.0% | $-744.70K | $28.09K | $772.79K | — |